We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
17:00 - 18:00
A3
Upper GI tract cancers
Arno Hessels, The Netherlands;
Martijn Intven, The Netherlands
Proffered Papers
Clinical
17:00 - 18:00
A prospective randomised trial to evaluate radiological response and surgical down staging after NACRT versus NACT in unresectable gall bladder cancer
Shabnum ., India
-1852
17:00 - 18:00
A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma: Short-Term Safety Data (NCT05203120)
Amalie Bjørn, Denmark
-3981
17:00 - 18:00
Sequential TACE, SBRT, and Anti-PD-L1 plus Anti-CTLA-4 Immunotherapy in Locally Advanced Hepatocellular Carcinoma: Survival Outcome of Phase II Trial
Chi Leung Chiang, China, Hong Kong Special Administrative Region
-2260
17:00 - 18:00
Continuation of first-line systemic therapy with radiotherapy in oligoprogressive hepatocellular carcinoma: a phase ? trial (NCT06261047)
Mingkai Dai, China
-748
17:00 - 18:00
Hepatobiliary infections and liver-function deterioration impact survival in locally advanced cholangiocarcinoma: post-hoc analysis of ABC-07 trial
YING ZHANG, United Kingdom
-2149
17:00 - 18:00
Carbon ion radiotherapy in non-metastatic pancreatic cancer: final results of the prospective Phase 2 PACK-study (NCT04194268)
Jakob Liermann, Germany
-3740